Jundishapur Journal of Microbiology

Published by: Kowsar

Characterization of the Same Mutations in FCA1 Gene Associated With 5-FC Resistance of Candida albicans

Xi-Ren Deng 1 , 2 , Fu-Cai Wang 1 , Mu-Ying Ying 1 , Jie-Yu Zhang 3 , Ying Ying 1 , Ling-Bing Zeng 4 , Xue-Fei Hu 4 , Ke Wang 1 , Qiong Liu 1 and Xiao-Tian Huang 1 , 2 , *
Authors Information
1 School of Medicine, Nanchang University, Nanchang 330006, China
2 Key Laboratory of Tumor Pathogenesis and Molecular Pathology, School of Medicine, Nanchang University, Nanchang 330006, China
3 Department of Pathophysiology, Fuzhou Medical School, Nanchang University, Fuzhou 344000, China
4 Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang 330006, China
Article information
  • Jundishapur Journal of Microbiology: August 2017, 10 (8); e12952
  • Published Online: July 24, 2017
  • Article Type: Brief Report
  • Received: February 11, 2017
  • Revised: May 13, 2017
  • Accepted: June 24, 2017
  • DOI: 10.5812/jjm.12952

To Cite: Deng X, Wang F, Ying M, Zhang J, Ying Y, et al. Characterization of the Same Mutations in FCA1 Gene Associated With 5-FC Resistance of Candida albicans, Jundishapur J Microbiol. 2017 ; 10(8):e12952. doi: 10.5812/jjm.12952.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
5.1. Conclusion
  • 1. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402): 207-14[DOI][PubMed]
  • 2. Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, et al. Active surveillance for candidemia, Australia. Emerg Infect Dis. 2006; 12(10): 1508-16[DOI][PubMed]
  • 3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20(1): 133-63[DOI][PubMed]
  • 4. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 62(4): 1-50[DOI][PubMed]
  • 5. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38(2): 161-89[DOI][PubMed]
  • 6. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994; 32(8): 1923-9[PubMed]
  • 7. Murray MP, Zinchuk R, Larone DH. CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test. J Clin Microbiol. 2005; 43(3): 1210-2[DOI][PubMed]
  • 8. Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J Clin Microbiol. 2003; 41(6): 2629-32[PubMed]
  • 9. Graf B, Adam T, Zill E, Gobel UB. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. J Clin Microbiol. 2000; 38(5): 1782-5[PubMed]
  • 10. Sariguzel FM, Berk E, Koc AN, Sav H, Aydemir G. Evaluation of chromogenic agar, [corrected] VITEK2 YST and VITEK(R) MS for identification of Candida strains isolated from blood cultures. Infez Med. 2015; 23(4): 318-22[PubMed]
  • 11. Chang HC, Leaw SN, Huang AH, Wu TL, Chang TC. Rapid identification of yeasts in positive blood cultures by a multiplex PCR method. J Clin Microbiol. 2001; 39(10): 3466-71[DOI][PubMed]
  • 12. Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol. 2002; 40(8): 2860-5[PubMed]
  • 13. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, et al. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol. 2001; 39(11): 4042-51[DOI][PubMed]
  • 14. C.L.S.I. . Reference method for broth dilution antifungal susceptibility testing of yeasts. 2008;
  • 15. Dassanayake RS, Ellepola AN, Samaranayake YH, Samaranayak LP. Molecular heterogeneity of fluconazole-resistant and -susceptible oral Candida albicans isolates within a single geographic locale. APMIS. 2002; 110(4): 315-24[PubMed]
  • 16. Dodgson AR, Dodgson KJ, Pujol C, Pfaller MA, Soll DR. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob Agents Chemother. 2004; 48(6): 2223-7[DOI][PubMed]
  • 17. Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011; 49(1): 325-34[DOI][PubMed]
  • 18. Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Florl C, Fegeler W, et al. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses. 2012; 55(3)-37[DOI][PubMed]
  • 19. Pongracz J, Juhasz E, Ivan M, Kristof K. Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014). Acta Microbiol Immunol Hung. 2015; 62(3): 317-29[DOI][PubMed]
  • 20. Pfaller MA, Castanheira M, Messer SA, Jones RN. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Mycoses. 2015; 58(4): 209-14[DOI][PubMed]
  • 21. Whelan WL, Kerridge D. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans. Antimicrob Agents Chemother. 1984; 26(4): 570-4[PubMed]
  • 22. Liu TT, Lee RE, Barker KS, Lee RE, Wei L, Homayouni R, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother. 2005; 49(6): 2226-36[DOI][PubMed]
  • 23. Whelan WL. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit Rev Microbiol. 1987; 15(1): 45-56[DOI][PubMed]
  • 24. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 1998; 11(2): 382-402[PubMed]
  • 25. Hope WW, Tabernero L, Denning DW, Anderson MJ. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob Agents Chemother. 2004; 48(11): 4377-86[DOI][PubMed]
  • 26. Quinto-Alemany D, Canerina-Amaro A, Hernandez-Abad LG, Machin F, Romesberg FE, Gil-Lamaignere C. Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis. PLoS One. 2012; 7(7)[DOI][PubMed]
  • 27. McManus BA, Moran GP, Higgins JA, Sullivan DJ, Coleman DC. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis. Antimicrob Agents Chemother. 2009; 53(11): 4678-85[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments